For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Augusta, Georgia 30912

0 studies enrolling now · 14 studies all time

What they study most

Advanced Non-Small Cell Lung Cancer, Colorectal Cancer, Cystic Fibrosis, Diabetic Kidney Disease, Diabetic Macular Edema, Diabetic Retinopathy, Exocrine Pancreatic Insufficiency, Locally Advanced Breast Cancer, Lymphoma, Follicular, Melanoma, Metastatic Breast Cancer, Non Small Cell Lung Cancer

Studies at this site

Study of Participants With Advanced Non-Small Cell Lung Cancer — Completed
A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease — Completed
A Study in Second Line Metastatic Colorectal Cancer — Completed
A Study of Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy — Completed
A Study of Enzastaurin in Participants With Follicular Lymphoma — Completed
A Study of Tasisulam-sodium Versus Paclitaxel as Treatment for Metastatic Melanoma — Stopped early
Reduction in the Occurrence of Center-Involved Diabetic Macular Edema — Completed
Effect of Ruboxistaurin on Clinically Significant Macular Edema — Completed
A Study of Pemetrexed, Carboplatin and Bevacizumab in Participants With Nonsquamous Non-Small Cell Lung Cancer — Completed
Open-Label Phase III Long-Term Safety Trial of Liprotamase — Completed
Docetaxel or Pemetrexed With or Without Cetuximab in Patients With Recurrent or Progressive Non-Small Cell Lung Cancer — Completed
Prasugrel Versus Placebo in Adult Sickle Cell Disease — Completed
Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer — Completed
A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC — Completed